Implement (240)

These files will help you implement and test what you have developed. Find exercise templates and advanced toolkits here. You can also go to the page.

Use the page arrows at the bottom of the page to browse the rest of this collection.
Or Click here for a sortable page with all 240 items in the Implement Collection

NETEC COVID-19 Webinar Series (11/25/20): Monoclonal Antibody Therapeutics: How to Operationalize mAB Therapy at Your Facility

Subject: Treatment & Care
Item Type: Webinar
Description: In this webinar, we will identify important considerations involving Monoclonal Antibody Therapeutics available for emergency use authorization (EUAs) for mild-to-moderate COVID-19 cases, discuss recent criteria for the FDA approved investigational…

Fact Sheet for Health Care Providers: Emergency Use Authorization (EUA) of BARICITINIB

Subject: Treatment & Care
Item Type: Guide
Description: EUA: For emergency use by healthcare providers for the treatment of suspected or laboratory-confirmed COVID-19 in hospitalized adults and pediatric patients 2 years of age or older requiring supplemental oxygen, invasive mechanical ventilation, or…

Fact Sheet for Health Care Providers: Emergency Use Authorization (EUA) of multiFiltrate PRO System and multiBic/multiPlus Solutions during the COVID-19 Pandemic

Subject: Treatment & Care
Item Type: Guide
Description: EUA: To provide continuous renal replacement therapy (CRRT) to treat patients in an acute care environment during the COVID-19 pandemic.

Fact Sheet for Health Care Providers: Emergency Use Authorization (EUA) of VEKLURY® (remdesivir) for Hospitalized Pediatric Patients weighing 3.5 kg to less than 40 kg OR Hospitalized Pediatric Patients less than 12 years of age weighing at least 3.5 kg.

Subject: Treatment & Care
Item Type: Guide
Description: EUA: For emergency use by licensed healthcare providers for the treatment of suspected or laboratory-confirmed COVID-19 in hospitalized pediatric patients weighing 3.5 kg to less than 40 kg or hospitalized pediatric patients less than 12 years of age…

Fact Sheet for Health Care Providers: Emergency Use Authorization (EUA) of FRESENIUS PROPOVEN 2% Emulsion

Subject: Treatment & Care
Item Type: Guide
Description: EUA: To maintain sedation via continuous infusion in patients older than age 16 with suspected or confirmed COVID-19 who require mechanical ventilation in an ICU setting 2

Fact Sheet for Healthcare Providers: REGIOCIT (Sodium Chloride and Sodium Citrate Renal Replacement and Regional Anticoagulant solution)

Subject: Treatment & Care
Item Type: Guide
Description: EUA: To be used as a replacement solution only in adult patients treated with continuous renal replacement therapy (CRRT), and for whom regional citrate anticoagulation is appropriate, in a critical care settingFor continuous renal replacement…

Fact Sheet for Health Care Providers: Emergency Use Authorization (EUA) of COVID-19 Convalescent Plasma for Treatment of COVID-19 in Hospitalized Patients

Subject: Treatment & Care
Item Type: Guide
Description: Fact sheet for Convalescent PlasmaEUA: For the treatment of hospitalized patients with Coronavirus Disease 2019 (COVID-19)

Fact Sheet for Heath Care Providers: Emergency Use Authorization (EUA) of Bamlanivimab

Subject: Treatment & Care
Item Type: Guide
Description: Fact sheet for Bamlanivimab.EUA: For the treatment of mild-to-moderate COVID-19 in adult and pediatric patients with positive results of direct SARS-CoV-2 viral testing who are 12 years of age and older weighing at least 40 kilograms (about 88…

NETEC COVID-19 Webinar Series (11/20/20): Pandemic Related Consent, Research and Ethics

Subject: Treatment & Care
Item Type: Webinar
Description: In this webinar, we will discuss the challenges involved when obtaining informed consent from a hospitalized patient who is in isolation related to COVID-19, articulate the obstacles and strategies involved when conducting research during a pandemic…

NETEC COVID-19 Webinar Series (11/18/20):  COVID-19 Therapeutics

Subject: Treatment & Care
Item Type: Webinar
Description: In this webinar, we will discuss current evidence surrounding clinical trials for COVID-19 therapeutics including ACTT1, ACTT2, and ACTT3, and describe the FDA's Coronavirus Treatment Acceleration Program (CTAP) when determining new treatments for…

Share this page: